# Tag: ONCO3

- [Wald family-linked fund seeks another Oncoclínicas board overhaul](https://brazilstockguide.com/insights/wald-family-linked-fund-seeks-another-oncoclinicas-board-overhaul/) (2026-09-30): UBS Lumen, which owns 4.93% of the company, wants to replace five of seven directors as the cancer-care group faces financial strain and a deepening shareholder dispute.
- [Oncoclínicas calls shareholder meeting after Latache seeks suspension of Josephina III rights](https://brazilstockguide.com/insights/oncoclinicas-latache-josephina-rights-tender-offer/) (2026-09-24): Funds want to temporarily suspend shareholder rights held by the Centaurus-linked vehicle until it complies with a mandatory tender offer ordered by Brazil’s securities regulator.
- [Oncoclínicas Shares Nearly Double in a Week as Volume Surges and Tender-Offer Dispute Returns to Focus](https://brazilstockguide.com/insights/oncoclinicas-shares-nearly-double-in-a-week-as-volume-surges-and-tender-offer-dispute-returns-to-focus/) (2026-08-19): ONCO3 jumped from R$0.56 to R$1.10 in seven days as daily trading activity nearly quadrupled; a potential CVM ruling on a mandatory tender offer adds an event-driven element to the stock.
- [CVM board to have final say on Oncoclínicas tender offer after SRE stands by ruling](https://brazilstockguide.com/insights/cvm-board-to-have-final-say-on-oncoclinicas-tender-offer-after-sre-stands-by-ruling/) (2026-08-14): Latache’s appeal will be decided by three members of the regulator’s board; Marina Copola has recused herself from the case.
- [Judge Curbs Health Plan Operators to Shield 98% of Oncoclínicas Revenue](https://brazilstockguide.com/insights/oncoclinicas-restructuring-health-plan-operators/) (2026-08-05): A 90-day injunction bars provider-network removals and commercial changes; industry source says it creates “contractual immunity” not expressly provided under bankruptcy law.
- [IG4 Offers Oncoclínicas R$ 500 Million as operator Disputes Threaten Restructuring Revenue](https://brazilstockguide.com/insights/ig4-offers-oncoclinicas-r-500-million-as-operator-disputes-threaten-restructuring-revenue/) (2026-07-16): Proposal includes convertible debentures and usufruct rights over shares, but amounts to less than 10% of the R$5.1 billion in debt covered by the restructuring plan.
- [CVM Staff Recommends Waiving Oncoclínicas Tender Offer, but Dispute Is Far From Over](https://brazilstockguide.com/insights/cvm-oncoclinicas-tender-offer-centaurus/) (2026-07-01): Minority shareholders challenge the process, the role of outside legal opinions, and are preparing an appeal to the regulator’s board of commissioners.
- [Listed Healthcare Companies Create Nearly 80,000 Jobs, Expanding Headcount by 48% Since 2019](https://brazilstockguide.com/insights/listed-healthcare-companies-create-nearly-80000-jobs-expanding-headcount-by-48-since-2019/) (2026-06-29): A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000 to 245,000 employees; Hapvida and Rede D’Or led the expansion.
- [Oncoclínicas scraps guidance amid weak performance](https://brazilstockguide.com/insights/oncoclinicas-scraps-guidance/) (2026-04-23): Company halts outlook citing macro pressures and recent results, removing key visibility for investors.
- [Board collapses at Oncoclínicas, opening control dispute](https://brazilstockguide.com/insights/board-collapses-at-oncoclinicas-opening-control-dispute/) (2026-04-07): Chairman Marcelo Gasparino’s resignation triggers full board removal under cumulative voting; MAK Capital ties funding to new board election.

Next page: https://brazilstockguide.com/tag/onco3/page/2/?format=markdown